Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Developing therapeutics for schizophrenia and other psychotic disordersGerard Marek, Kalpana Merchant
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 23, 2013
Effect of ketoconazole on the pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 and its two active metabolites in healthy volunteers: population analysis of data from a drug-drug interaction studyGuohua An, Wei Liu, David A Katz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 19, 2009
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorderJohannes Tauscher, William Kielbasa, Smriti Iyengar, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 27, 2010
Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in ratsAgnieszka Nikiforuk, Piotr Popik, Karla U Drescher, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
No evidence for direct physical interaction of 5-HT 2A -mGluR2 receptors in vitro or in vivoBlake A Fordyce, Yi-Ting Chiu, Nicholas J Wright, et al.
Pageof 1